Business
Axcan Pharma to present at the Scotia Capital Pharmaceutical & Biotechnology Conference
Axcan Pharma to present at the Scotia Capital Pharmaceutical & Biotechnology Conference.
About this update from Trailbreaker Resources Ltd
[{"type":"text","content":"\n\n\n\n\nTSX SYMBOL (Toronto Stock Exchange): AXP\nNASDAQ SYMBOL (NASDAQ National Market): AXCA\n\nMONT-SAINT-HILAIRE, QC, April 19 /CNW Telbec/ - Axcan Pharma Inc.\n(\"Axcan\" or the \"Company\") today announced that on Wednesday, April 26th,\n2006, President and Chief Executive Officer, Frank A.G.M. Verwiel, M.D., will\npresent an overview of the Company at the Scotia Capital Pharmaceutical &\nBiotechnology Conference to be held in Toronto, ON. This presentation will\ntake place at 11:10 a.m. (Eastern time).\nA webcast of Axcan's presentation will also be accessible via the\nCompany's website at www.axcan.com.\n\nAxcan is a leading specialty pharmaceutical company involved in the field\nof gastroenterology. The Company markets a broad line of prescription products\nsold for the treatment of symptoms in a number of gastrointestinal diseases\nand disorders such as inflammatory bowel disease, irritable bowel syndrome,\ncholestatic liver diseases and complications related to cystic fibrosis.\nAxcan's products are marketed by its own sales force in North America and\nEurope. Its common shares are listed on the Toronto Stock Exchange under the\nsymbol \"AXP\" and on the NASDAQ National Market under the symbol \"AXCA\".\n\n\n","length":1348,"tagName":"div"}]